Clark S L
National Institutes of Health, Bethesda, Maryland.
Obstet Gynecol. 1993 Dec;82(6):1036-40.
This manuscript is a summary of a comprehensive report dealing with asthma and pregnancy issued by the working group on Asthma and Pregnancy, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The report was developed by a panel of obstetricians, pharmacologists, internists, allergists, and pulmonologists, who met over an 18-month period under the auspices of the NIH. Undertreatment of pregnant asthmatics, partially because of unfounded fears of adverse pharmacologic effects on the developing fetus, remains the major problem in the management of asthma during pregnancy in the United States. The four key components of asthma management during pregnancy are: 1) objective assessment of maternal lung function and fetal well-being, 2) avoidance or control of environmental precipitating factors, 3) pharmacologic therapy, and 4) patient education.
本手稿是国立卫生研究院（NIH）国家心肺血液研究所哮喘与妊娠工作组发布的一份关于哮喘与妊娠的综合报告的摘要。该报告由一组产科医生、药理学家、内科医生、过敏症专科医生和肺病专家共同撰写，他们在国立卫生研究院的支持下，历经18个月完成。在美国，孕期哮喘患者治疗不足仍是孕期哮喘管理中的主要问题，部分原因是对药物对发育中胎儿的不良影响存在无端恐惧。孕期哮喘管理的四个关键要素为：1）对母亲肺功能和胎儿健康状况进行客观评估；2）避免或控制环境诱发因素；3）药物治疗；4）患者教育。
